COPYCAT
Live / Registered — Registered (as of 23 May 2023)
What this means for you
Registered since 23 May 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 May 2029: the §8 declaration of use).
Record
- Serial number
- 90197306
- Registration number
- 7062574
- Mark type
- Word mark
- Filed
- 21 Sept 2020
- Published for opposition
- 12 Apr 2022
- Registered
- 23 May 2023
- Next maintenance filing
- §8 declaration of use, due by 23 May 2029 (grace period to 23 Nov 2029)
- Attorney of record
- Michael A. Blake
Goods and services
- Class 005 — Pharmaceuticals: placebo mixes for medical purposes, placebo pills for medical purposes, simulated narcotics being placebo pills for medical purposes, simulated drugs being placebo pills for medical purposes, simulated mind altering substances being placebo pills for medical purposes, simulated illegal ingestable substances being placebo pills for medical purposes; none of the foregoing goods containing narcotics or mind altering substances
Owner
- Connecticut Analtyical Corporation, Bethany, CT, US
- Connecticut Analtyical Corporation, Bethany, CT, US
- Connecticut Analtyical Corporation, Bethany, CT, US
Prosecution history
- 23 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Mar 2023 — ASSIGNED TO EXAMINER
- 06 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Dec 2022 — USE AMENDMENT FILED
- 06 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Jun 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Mar 2022 — EXAMINER'S AMENDMENT ENTERED